Insider Transactions

DOVER Corp (DOV) Insider Transactions

Over the last 12 months, 15 DOVER Corp (DOV) insiders filed 80 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $20.0M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 80 (1-year window)

Each row is a single Form 4 filing event for DOV, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-03-13 Yehle Jeffrey Senior VP & CHRO Grant $12.9K 63 $204.28
2026-03-13 Moran James M VP & Treasurer Grant $5.5K 27 $204.28
2026-03-13 Moran James M VP & Treasurer Grant $5.3K 26 $204.28
2026-03-13 Moran James M VP & Treasurer Grant $4.1K 20 $204.28
2026-03-13 Tobin Richard J Chairman, President & CEO Grant $354.2K 1,734 $204.28
2026-03-13 Tobin Richard J Chairman, President & CEO Grant $374.9K 1,835 $204.28
2026-03-13 Tobin Richard J Chairman, President & CEO Grant $317.7K 1,555 $204.28
2026-03-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $37.4K 183 $204.28
2026-03-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $35.7K 175 $204.28
2026-03-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $56.6K 277 $204.28
2026-03-13 Juneja Girish Senior VP & CDO Grant $19.8K 97 $204.28
2026-03-13 Juneja Girish Senior VP & CDO Grant $18.8K 92 $204.28
2026-03-13 Juneja Girish Senior VP & CDO Grant $17.0K 83 $204.28
2026-03-13 Paulson Ryan VP & Controller Grant $6.5K 32 $204.28
2026-03-13 Paulson Ryan VP & Controller Grant $7.6K 37 $204.28
2026-03-13 Paulson Ryan VP & Controller Grant $6.1K 30 $204.28
2026-03-13 Woenker Christopher B. Senior VP & CFO Grant $8.0K 39 $204.28
2026-03-13 Woenker Christopher B. Senior VP & CFO Grant $8.8K 43 $204.28
2026-03-13 Woenker Christopher B. Senior VP & CFO Grant $19.8K 97 $204.28
2026-02-19 Tobin Richard J Chairman, President & CEO Grant $0 210,658 $0.00
2026-02-19 Tobin Richard J Chairman, President & CEO Grant $16.8M 72,422 $231.98
2026-02-19 Tobin Richard J Chairman, President & CEO Grant $14.2M 61,239 $231.98
2026-02-19 Tobin Richard J Chairman, President & CEO Grant $0 210,658 $0.00
2026-02-19 Tobin Richard J Chairman, President & CEO Sell $17.9M 76,997 $232.70
2026-02-17 Cabrera Ivonne M SVP, General Counsel & Secr. Sell $932.9K 4,000 $233.23
2026-02-13 Yehle Jeffrey Senior VP & CHRO Grant $0 648 $0.00
2026-02-13 Yehle Jeffrey Senior VP & CHRO Grant $0 5,756 $0.00
2026-02-13 Tobin Richard J Chairman, President & CEO Grant $0 10,361 $0.00
2026-02-13 Tobin Richard J Chairman, President & CEO Grant $665.0M 25,788 $25788.00
2026-02-13 Tobin Richard J Chairman, President & CEO Grant $2.5M 10,777 $231.63
2026-02-13 Tobin Richard J Chairman, President & CEO Grant $0 92,101 $0.00
2026-02-13 Paulson Ryan VP & Controller Grant $0 259 $0.00
2026-02-13 Paulson Ryan VP & Controller Grant $0 679 $0.00
2026-02-13 Paulson Ryan VP & Controller Grant $52.6K 227 $231.63
2026-02-13 Paulson Ryan VP & Controller Grant $0 2,303 $0.00
2026-02-13 Moran James M VP & Treasurer Grant $0 194 $0.00
2026-02-13 Moran James M VP & Treasurer Grant $0 610 $0.00
2026-02-13 Moran James M VP & Treasurer Grant $41.5K 179 $231.63
2026-02-13 Moran James M VP & Treasurer Grant $0 1,727 $0.00
2026-02-13 Juneja Girish Senior VP & CDO Grant $0 820 $0.00
2026-02-13 Juneja Girish Senior VP & CDO Grant $0 2,036 $0.00
2026-02-13 Juneja Girish Senior VP & CDO Grant $145.5K 628 $231.63
2026-02-13 Juneja Girish Senior VP & CDO Grant $0 7,291 $0.00
2026-02-13 Woenker Christopher B. Senior VP & CFO Grant $0 1,079 $0.00
2026-02-13 Woenker Christopher B. Senior VP & CFO Grant $0 814 $0.00
2026-02-13 Woenker Christopher B. Senior VP & CFO Grant $60.7K 262 $231.63
2026-02-13 Woenker Christopher B. Senior VP & CFO Grant $0 9,594 $0.00
2026-02-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $0 1,727 $0.00
2026-02-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $0 2,714 $0.00
2026-02-13 Cabrera Ivonne M SVP, General Counsel & Secr. Grant $282.8K 1,221 $231.63

Showing the most recent 50 of 80 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track DOV Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for DOVER Corp?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of DOVER Corp (DOV) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of DOVER Corp (DOV) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.